Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis

摘要

Objectives To evaluate maintenance of response while reducing intravenous abatacept dose from similar to 10 mg/kg to similar to 5 mg/kg in patients with early rheumatoid arthritis (RA) who achieved disease activity score (DAS) 28 (erythrocyte sedimentation rate, ESR) <2.6.